EQT Life Sciences and LSP 7 Lead $56M Series D in Neuros Medical

Trinity Capital Commits $35 Million Growth Capital to Neuros Medical to Scale Altius Pain Therapy Adoption

March 10, 2026

Healthcare Services

Trinity Capital Inc. committed $35 million in growth capital to Neuros Medical, Inc. to scale commercialization of its FDA-approved Altius Direct Electrical Nerve Stimulation System. The funding is intended to expand market access and improve financial flexibility as Neuros enters the next phase of adoption for post-amputation pain therapy.

EQT Life Sciences and Gimv Co-Lead €51M Series B in Exciva

January 20, 2026

Biotechnology

EQT Life Sciences (via its LSP Dementia Fund) and Gimv co-led a €51 million Series B in German clinical-stage biopharmaceutical company Exciva to fund a Phase 2 trial of its lead candidate, Deraphan, for agitation associated with Alzheimer's disease. Additional participants included Fountain Healthcare Partners, LifeArc, Carma Fund, Modi Ventures, Andera Partners, LBBW and returning investors; proceeds will support multinational Phase 2 studies across the EU, United States and Canada.

EQT Future and ATHOS Lead Minority Investment in SHL Medical

December 9, 2022

Medical Devices

EQT Future, ATHOS and other co-investors have acquired a minority stake in SHL Medical from EQT's Equity fund VIII, with founder Roger Samuelsson remaining the majority shareholder. The consortium will support SHL Medical's next growth phase — expanding production into the United States and Europe, launching new product platforms, and advancing sustainability and circularity initiatives.

EQT Acquires LSP (Life Sciences Partners)

November 10, 2021

Financial Services

EQT AB has acquired LSP (Life Sciences Partners), a leading European life-sciences venture capital firm, in a transaction that creates a new EQT Life Sciences business line. The deal values the upfront consideration at EUR 450 million (25% cash / 75% EQT shares) with a EUR 25 million earn‑out paid on meeting fundraising targets (total consideration EUR 475 million at close); LSP's 34-person team and partners join EQT to strengthen its healthcare investing capabilities.

Public Pension Capital Invests in Life Science Outsourcing, Inc.

January 25, 2021

Medical Devices

Public Pension Capital, a New York-based private equity fund, made an investment in Life Science Outsourcing, Inc., a Brea, California-based contract manufacturer serving medical device companies. The transaction, completed January 25, 2021, will support LSO's medical package testing, validation, sterilization and distribution services and help accelerate the company's growth and capacity to serve device startups and larger OEMs.

EQT Acquires Minority Stake in SHL Medical

January 3, 2020

Medical Devices

EQT VIII (EQT) has agreed to acquire a minority stake in SHL Medical, a Switzerland-headquartered manufacturer of advanced drug delivery devices including autoinjectors. The investment will support SHL's next phase of growth, innovation and digitization while leveraging EQT's healthcare expertise; the deal is subject to customary regulatory approvals.